Shows
A Chat with AnatNew options for an old disease: Treatment of CSCIn this episode, I am joined by my fellow Vision Academy member Professor Sobha Sivaprasad, Professor of Retinal Clinical Studies at the UCL Institute of Ophthalmology and Consultant Ophthalmologist at Moorfields Eye Hospital in the United Kingdom. Join us as we discuss key aspects of the diagnosis and treatment of central serous chorioretinopathy (CSC). In this episode, we summarize published evidence for the treatment of CSC, and use the guidance developed by the Vision Academy to discuss practical disease management and treatment of phenotypic variations. We also dive into cases we have treated in our own clinics, a...
2026-01-2723 min
A Chat with AnatTogether We Care: HCP Well-being in OphthalmologyIn this special episode filmed in Paris at EURETINA 2025, I am joined by a very special guest, my fellow Vision Academy and Barometer Program member Prof. Adrian Koh, who is founding partner and senior consultant at the Eye & Retina Surgeons, Camden Medical Centre, Singapore, and Director of Retinal Centre International.Tune in as we dive into the current understanding of the well-being of healthcare professionals (HCPs) working in ophthalmology, and introduce the HCP Barometer Survey, the first comprehensive and holistic analysis of the complexities of HCP well-being in ophthalmology, from professional fulfilment to the impact of clinic...
2025-12-0522 min
A Chat with AnatConsensus on the diagnosis and management of simultaneous GA and CNV/MNVIn this special episode filmed in Paris at EURETINA 2025, I am joined by Professor Gemmy Cheung, Professor and Senior Consultant Ophthalmologist at the Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore, and my fellow Vision Academy and Barometer Program. Join us as we explore current guidance for the diagnosis and management of simultaneous geographic atrophy (GA) and choroidal/macular neovascularization (CNV/MNV) in clinical practice from the Vision Academy’s viewpoint. In this episode, Gemmy and I dive into insights from published literature on the clinical profile and pathophysiology of the disease and the rec...
2025-11-2516 min
A Chat with AnatFrom the Community, For the CommunityIn this special episode, I am joined by two of my long-time friends and collaborators, Professor Jean-François Korobelnik, my Co-chair of the Vision Academy and Professor of Ophthalmology at the University Hospital of Bordeaux, France, and Dr Jane Barratt, my Co-chair of the Barometer Program, and former Secretary General and Global Advisor at the International Federation of Ageing.Tune in as we unpack the statement “From the Community, For the Community,” exploring how collaborations between academia, industry, and non-governmental organizations shape clinical practice and influence policy, with practical advice for listeners keen to get involved in such...
2025-08-0723 min
A Chat with AnatThe Hot SeatIn this special episode, the roles have been reversed! Your host is Professor Tariq Aslam, Professor of Ophthalmology and Interface Technologies at the University of Manchester in the United Kingdom, who asked me questions sent in by my retinal community colleagues.Tune in to hear how I balance my busy career with my well-being, the pep talks I give to nervous first-time patients and trainees, myths about retinal disease I’d like to erase forever, and even an embarrassing moment in my career! This episode was recorded live at the Joint Vision Academy Steering Committee and...
2025-07-0825 min
A Chat with AnatMonitoring the fellow eye in nAMDMy guest for this special episode is Professor Paolo Lanzetta, Chair of the Department of Ophthalmology at the University of Udine, Italy. In this episode, Paolo and I explore the importance of monitoring the fellow eye of patients with nAMD. We also discuss methods and techniques for early detection of disease, the difference in monitoring for patients with DME, and the Vision Academy’s evidence-based guidance on monitoring the fellow eye. To learn more about monitoring the fellow eye in patients with nAMD, read the Vision Academy Viewpoint, the Vision Academy slide deck, and the Vision Academy pub...
2025-05-1219 min
A Chat with AnatChoosing the right regimen for patients with nAMDMy guest for this special episode is Prof. Jean- François Korobelnik from the Department of Ophthalmology at the University Hospital, and at CHU Bordeaux, in Bordeaux, France. In this episode, Jean-François and I explore the importance of choosing the right regimen for our patients with nAMD. We discuss the evidence we can gather from clinical trials, and the lessons we learn from patients we see during clinical practice. We also explore the algorithm developed by the Vision Academy to choose the best regimen for patients.To learn more about how to choose the best treatment re...
2025-04-1112 min
A Chat with AnatRevolutionizing holistic patient care: Innovations and technologiesMy guest for this special episode is Dr. John Kitchens, Vitreoretinal Surgeon with Retina Associates of Kentucky in the USA. In this episode, John and I explore the importance of holistic patient care. We also highlight the latest advances in home monitoring technologies in retinal disease, and how artificial intelligence (AI) can be used to aid in disease monitoring and optimization of clinic organization. To learn more about the current status of AI in screening, diagnosing and managing retinal diseases, read the Vision Academy Viewpoint, and the Vision Academy retinal expert consensuses by clicking here or here. F...
2025-01-0817 min
A Chat with AnatTreatment futility and success in the context of suspending treatmentMy guest for this episode is Professor David Wong from the Department of Ophthalmology and Vision Sciences, University of Toronto and Unity Health Toronto in Toronto, Canada. In this episode, David and I discuss the Vision Academy’s algorithms for suspending treatment for nAMD in the context of treatment futility and success. Our conversation highlights the monitoring considerations and criteria used to define treatment futility and success, and the potential of predictive biomarkers and at-home monitoring to optimize patient follow-up. Important resources, such as the Vision Academy Viewpoint and algorithm on suspending treatment of nAMD in cases of...
2024-11-0716 min
A Chat with AnatWorld Sight Day and collaboration for change in eye healthMy guest for this special episode is Peter Holland, Chief Executive of the International Agency for the Prevention of Blindness (IAPB). We speak about the importance of World Sight Day, and discuss how different initiatives, such as the Love Your Eyes campaign, have helped put eye health on the global agenda in collaboration with members and partners.We also highlight how clinicians can leverage their voices and influence to share knowledge, shape policies, and strengthen cross-sector collaborations, leading to the development of important resources for patients and clinicians to improve care. We recommend visiting the IAPB’s we...
2024-10-1015 min
A Chat with AnatEqual Vision – Women in OphthalmologyMy guests for this episode are Professor Sobha Sivaprasad, Consultant Ophthalmologist at Moorfields Eye Hospital and Professor of Retinal Clinical Studies at the UCL Institute of Ophthalmology in London, and Professor Gemmy Cheung, Professor and Senior Consultant Ophthalmologist at the Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore. In this special episode, we discuss our experiences as women working in ophthalmology, and the advice we would give to young, aspiring ophthalmologists.We also talk about what it meant to us to be named on The Ophthalmologist’s Power List, and how the next generation of...
2024-09-0221 min
A Chat with AnatImpact of residual fluid on treatment outcomes in nAMDIn this episode, my guests Vision Academy and Barometer Program member Professor Jean-François Korobelnik, Professor and Head of the Ophthalmology Department at the University Hospital of Bordeaux in France, and Vision Academy member Professor Robyn Guymer, Deputy Director at the Centre for Eye Research and Professor of Ophthalmic at the University of Melbourne in Australia, discuss considerations for devising flexible and individualized treatment regimens for patients with nAMD with residual fluid.Using examples from their own clinical experience, Professors Korobelnik and Guymer explore the nuanced relationship between efficacy of anti-VEGF treatment and location and presence (or a...
2024-08-0826 min
A Chat with AnatPachychoroid: Current concepts on clinical features and pathogenesisIn this episode, Vision Academy members Professor Annabelle Okada, Professor of Ophthalmology and Director of the Ocular Inflammation Service and the Macular Disease Service at the Kyorin University School of Medicine in Japan, and Professor Ian Pearce, Consultant Ophthalmologist and Vitreoretinal Surgeon at the Royal Liverpool University Hospital in the UK, discuss the pachychoroid spectrum.Using practical examples from their own clinics, they explore how accurate diagnosis, monitoring, prognosis and treatment decisions depend upon consensus descriptions of clinical, morphological and epidemiological characteristics disorders on the pachychoroid spectrum. They also discuss multimodal imaging and barriers to its implementation...
2024-07-0828 min
A Chat with AnatAre we entering a new era for patients and clinicians?My guest for this special episode recorded live at the 15th Annual Congress on Controversies in Ophthalmology (COPHy) is Professor Tariq Aslam, Professor of Ophthalmology and Interface Technologies at University of Manchester, United Kingdom. In this episode, Tariq and I discuss whether the introduction of next generation therapies for the clinical management of retinal diseases will open the door to a new era for patients and clinicians.We also consider how learnings from the Barometer Global Survey surrounding the multiple challenges associated with management of retinal diseases can be implemented into clinical practice, and touch o...
2024-06-1813 min
A Chat with AnatCharacterization of macular neovascularization subtypes in nAMD to optimize treatment outcomesMy guest for this episode is Professor Nicole Eter, Professor of Ophthalmology and Chair of the Department of Ophthalmology at the University of Münster, Germany. In this episode, Nicole and I chat about the different macular neovascularization (MNV) subtypes, discussing the diagnostic tools used to classify MNV subtypes, their defining characteristics and variants, and the impact of these on our patients. Our conversation highlights why it’s important to tailor treatment to MNV subtype for our patients to have the best outcomes, and the significance of discussing lesions, prognoses and treatments with patients and their caregivers. Imp...
2024-05-1420 min
A Chat with AnatOptimal anti-VEGF therapy regimenIn this episode, Professor Paul Mitchell, Professor of Ophthalmology at the University of Sydney in Australia, and Dr Andrew Chang, Principal Retinal Specialist at the Sydney Retina Clinic and Day Surgery in Australia, share their thoughts on the optimal anti-VEGF therapy regimens to treat retinal vascular diseases, including nAMD and DME. They discuss how the best regimen should be effective in maintaining vision, proactive, individualized to the patient’s needs, and convenient for the patient.Using practical examples from their own clinics, Professor Mitchell and Dr Chang explore how to treat different patients with different levels of st...
2023-09-2528 min
A Chat with AnatReducing the burden of bilateral injectionsWe are delighted to announce that we are expanding A Chat with Anat! We will be partnering with the Vision Academy, a group of retinal experts who collaborate to provide guidance to the retinal community. I will be joined by internationally renowned Vision Academy experts to discuss practice-focused topics covering clinical challenges in ophthalmology and controversies in care. In this episode of A Chat with Anat, Professor Paul Mitchell, Professor of Ophthalmology at the University of Sydney, and Dr Alex Hunyor, Associate Professor of Ophthalmology at the University of Sydney, discuss pragmatic considerations to reduce the burden o...
2023-07-2120 min
A Chat with AnatNavigating anxiety and depression in patients with nAMDMy guest for this episode is Professor Tariq Aslam, Professor of Ophthalmology and Interface Technologies at the University of Manchester and a Consultant Ophthalmologist specializing in the management of retinal disease. In this episode, we speak about how important it is to consider anxiety and depression when managing our patients with nAMD, and hear about the quick and effective measures that listeners can implement in their own clinic to identify patients at risk of anxiety and depression.Visit the resources page of the Barometer website to learn more about the rapid mental health screening tool that can...
2023-01-1716 min
A Chat with AnatExploring the research gap of patient perspectivesMy guest for this episode is Professor Richard Gale, Professor of Ophthalmology at Hull York Medical School, University of York, UK, and Honorary Consultant Medical Ophthalmologist at the National Health Service’s York Teaching Hospital. In this episode, Richard and I will chat about how patients’ emotions, experiences, and perceptions related to anti-vascular endothelial growth factor (anti-VEGF) treatment can influence their treatment adherence and persistence. Despite this, the patient’s perspective is often not considered during the clinical management of neovascular age-related macular degeneration. To tackle this issue, Richard gives us some of his top tips to try in...
2022-11-1517 min
A Chat with AnatEvolution of patient expectations in nAMD through the 21st centuryMy guest for this episode is Professor Paul Mitchell, Emeritus Professor of Ophthalmology at the University of Sydney, Consultant Ophthalmologist at the Western Sydney Local Health District, and Principal of Sydney West Retina Pty Ltd in Australia. As treatment for neovascular age-related macular degeneration (nAMD) has evolved through the 21st century, so have the expectations of our patients. Paul joins me to chat about how developments in treatment modalities and regimens led to the evolution of patient expectations following diagnosis of nAMD, and what we can expect for our patients in the future.If you...
2022-08-1917 min
A Chat with AnatWays to engage with patients to enable realistic expectation-settingMy guest is Dr. Jane Barratt, Secretary General of the International Federation on Ageing. In this episode, Jane and I discuss ways in which we can improve our communication with our patients to enable realistic expectation-setting. We also speak about how we can meaningfully engage with, and empower, our patients to support them in managing their nAMD.This is not intended for UK audiences.Speaker disclosures:Professor Anat LoewensteinConsultancy, Research grants: Allergan, Bayer, Beyeonics Surgical, KHB, Novartis, Notal Vision, Oculis, Oxurion, Pres-By, Roche, Sensor, WebMD, Xbrane...
2022-03-0119 min
A Chat with AnatHow to improve your clinic organization to ensure a better patient experience, and optimize adherence to treatmentToday my guest is Mr James Talks, Consultant Ophthalmologist at the Newcastle Eye Centre in Newcastle, UK. He joins me to discuss how clinic organization can impact adherence and persistence and what aspects we can modify to ensure a better patient experience and optimize adherence to treatment.This is not intended for UK audiences. Speaker disclosures:Professor Anat LoewensteinConsultancy, Research grants: Allergan, Bayer, Beyeonics Surgical, KHB, Novartis, Notal Vision, Oculis, Oxurion, Pres-By, Roche, Sensor, WebMD, Xbrane Mr James TalksConsultancy, Research grants: Allergan...
2021-10-2716 min
A Chat with AnatHow to motivate my patient to be adherentMy first guest is Professor Richard Gale, Consultant Medical Ophthalmologist, and the Clinical Director at the York Teaching Hospital NHS Foundation Trust, UK. In this episode, we discuss the latest publications and strategies that are employed to support patients in continuing to attend appointments and receive treatment. I have included below the links to the publications that we discuss during this podcast.Okada M, et al. Ophthalmology. 2021;128(2):234-47Okada M, et al. JAMA Ophthalmol. 2021;139(7):769-76This is not intended for UK audiences.Speaker disclosures: Professor Anat Loewenstein
2021-10-0115 min